1. Home
  2. WILC vs JUNS Comparison

WILC vs JUNS Comparison

Compare WILC & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WILC
    SELLHOLDBUYas of 4 days ago
  • JUNS
    SELLHOLDBUYas of 2024 years ago
  • Stock Information
  • Founded
  • WILC 1994
  • JUNS 2015
  • Country
  • WILC Israel
  • JUNS United States
  • Employees
  • WILC N/A
  • JUNS N/A
  • Industry
  • WILC Food Distributors
  • JUNS
  • Sector
  • WILC Consumer Discretionary
  • JUNS
  • Exchange
  • WILC Nasdaq
  • JUNS NYSE
  • Market Cap
  • WILC N/A
  • JUNS 281.4M
  • IPO Year
  • WILC 1997
  • JUNS 2024
  • Fundamental
  • Price
  • WILC $15.21
  • JUNS $0.60
  • Analyst Decision
  • WILC
  • JUNS
  • Analyst Count
  • WILC 0
  • JUNS 0
  • Target Price
  • WILC N/A
  • JUNS N/A
  • AVG Volume (30 Days)
  • WILC 6.5K
  • JUNS 119.9K
  • Earning Date
  • WILC 03-11-2025
  • JUNS 05-11-2025
  • Dividend Yield
  • WILC 3.98%
  • JUNS N/A
  • EPS Growth
  • WILC 122.00
  • JUNS N/A
  • EPS
  • WILC 1.39
  • JUNS N/A
  • Revenue
  • WILC $158,085,550.00
  • JUNS N/A
  • Revenue This Year
  • WILC N/A
  • JUNS N/A
  • Revenue Next Year
  • WILC N/A
  • JUNS N/A
  • P/E Ratio
  • WILC $10.93
  • JUNS N/A
  • Revenue Growth
  • WILC 5.99
  • JUNS N/A
  • 52 Week Low
  • WILC $8.18
  • JUNS $0.55
  • 52 Week High
  • WILC $17.58
  • JUNS $19.51
  • Technical
  • Relative Strength Index (RSI)
  • WILC 33.74
  • JUNS N/A
  • Support Level
  • WILC $15.03
  • JUNS N/A
  • Resistance Level
  • WILC $16.30
  • JUNS N/A
  • Average True Range (ATR)
  • WILC 0.63
  • JUNS 0.00
  • MACD
  • WILC -0.14
  • JUNS 0.00
  • Stochastic Oscillator
  • WILC 7.14
  • JUNS 0.00

Stock Price Comparison Chart: WILC vs JUNS

WILC
JUNS
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025024681012141618202224WILC VS JUNS

About JUNS JUPITER NEUROSCIENCES INC

Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use